David W Gryska's Net Worth

$26.7 Million

Estimate Recalculated Nov 11, 2024 02:43AM EST

Who is David W Gryska?

David W Gryska has an estimated net worth of $26.7 Million. This is based on reported shares across multiple companies, which include SEATTLE GENETICS INC /WA, GW PHARMACEUTICALS PLC, INCYTE CORP, COTHERIX INC, HYPERION THERAPEUTICS INC, AERIE PHARMACEUTICALS INC, CELGENE CORP /DE/, Mind Medicine (MindMed) Inc., Forte Biosciences, Inc., PDL BIOPHARMA, INC., ARGOS THERAPEUTICS INC, and Myrexis, Inc..

SEC CIK

David W Gryska's CIK is 0001202335

Past Insider Trading and Trends

2022 was David W Gryska's most active year for acquiring shares with 15 total transactions. David W Gryska's most active month to acquire stocks was the month of April. 2022 was David W Gryska's most active year for disposing of shares, totalling 26 transactions. David W Gryska's most active month to dispose stocks was the month of October. 2017 saw David W Gryska paying a total of $4,298,574.20 for 168,697 shares, this is the most they've acquired in one year. In 2023 David W Gryska cashed out on 122,934 shares for a total of $11,221,687.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SEATTLE GENETICS INC /WA (SGEN) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-49.00K
$229.00
-$11,221,687.00
0
Dec 14
Form 4
+4.17%
2.04K
—
—
51.05K
May 31
Form 4
+21.74%
8.75K
$36.70
$321,125.00
49K
Feb 13
Form 4
-15.71%
-7.50K
$129.10
-$968,220.00
40.25K
Nov 11
Form 4
+3.25%
1.5K
—
—
47.75K
May 13
Form 4
—
0
$82.01
-$495,543.00
46.25K
Scheduled
Apr 19
Form 4
—
0
$79.41
-$534,170.96
46.25K
Scheduled
Feb 7
Form 4
—
0
$71.31
-$461,268.88
46.25K
Scheduled
Jan 28
Form 4
—
0
$77.65
-$518,310.90
46.25K
Scheduled
Jan 14
Form 4
+3.13%
1.4K
—
—
46.25K
May 14
Form 4
—
0
$96.36
-$2,320,222.55
44.85K
Nov 19
Form 4
-9.12%
-4.50K
$180.60
-$812,699.10
44.85K
Nov 5
Form 4
+2.78%
1.33K
—
—
49.35K
May 15
Form 4
—
0
$50.49
-$346,000.00
48.01K
Scheduled
Oct 1
Form 4
—
0
$43.88
-$311,200.00
48.01K
Scheduled
Jul 17
Form 4
+6.58%
2.96K
—
—
48.01K
May 20
Form 4
—
0
$43.09
-$303,229.78
45.05K
Scheduled
Apr 1
Form 4
—
0
$38.90
-$261,400.00
45.05K
Scheduled
Jan 8
Form 4
+8.95%
3.7K
—
—
45.05K
May 18
Form 4
+9.83%
3.7K
—
—
41.35K
May 19
Form 4
+36.17%
10K
$10.20
$102,000.00
37.65K
Sep 6
Form 4
+15.45%
3.7K
—
—
27.65K
May 20
Form 4
-29.46%
-10.00K
$43.57
-$435,737.00
23.95K
Nov 5
Form 4
+12.23%
3.7K
—
—
33.95K
May 15
Form 4
+19.80%
5K
$8.38
$41,900.00
30.25K
Apr 8
Form 4
+16.09%
3.5K
—
—
25.25K
May 16
Form 4
—
0
$26.28
-$324,000.00
22K
Sep 3
Form 4
+18.92%
3.5K
—
—
22K
May 17
Form 4
—
0
$16.93
-$204,800.00
18.5K
Feb 25 - Feb 26
Form 4
+65.22%
7.5K
$5.00
$37,500.00
19K
Aug 10
Form 4
-41.03%
-8.00K
$19.75
-$158,000.00
11.5K
Jun 5
Form 4
—
0
—
—
0
May 18
Form 4
+30.00%
4.5K
$5.00
$22,500.00
19.5K
Dec 15
Form 4
-40.00%
-10.00K
$18.09
-$180,917.00
15K
Dec 9
Form 4
—
0
—
—
0
May 20
Form 4
+18.60%
4K
$5.00
$20,000.00
25.5K
Nov 12
Form 4
—
0
—
—
0
May 21
Form 4
+22.86%
4K
$4.18
$16,720.00
21.5K
Feb 17
Form 4
+29.63%
4K
$5.00
$20,000.00
17.5K
Jul 20
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 16
Form 4
+80.00%
6K
$4.18
$25,080.00
13.5K
Jan 17
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 19
Form 4
+50.00%
2.5K
$4.59
$11,484.00
7.5K
May 9
Form 4
∞
5K
$4.91
$24,574.48
5K
Feb 14
Form 4
—
0
—
—
0
Mar 25
Form 3
—
0
—
—
0
No matching records found

GW PHARMACEUTICALS PLC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
Feb 22
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found

INCYTE CORP (INCY) Snapshot price: $60.96

Executive Vice President, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-4.26%
-455.00
$70.19
-$31,936.45
10.23K
Jul 16
Form 4
-2.55%
-280.00
$68.28
-$19,118.40
10.69K
Jul 2 - Jul 5
Form 4
-21.60%
-3.02K
$85.73
-$259,065.22
10.97K
Scheduled
Feb 20 - Feb 21
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
$91.35
-$101,670.40
13.99K
Scheduled
Jan 5
Form 4
-35.88%
-7.83K
$106.79
-$835,988.93
13.99K
Scheduled
Nov 1 - Nov 2
Form 4
-3.16%
-712.00
$123.15
-$87,682.80
21.82K
Sep 13
Form 4
+18.50%
3.52K
—
—
22.53K
Jul 5
Form 4
—
0
$101.48
-$33,861.47
19.02K
Scheduled
Jun 30
Form 4
—
0
$94.91
-$727,042.84
19.02K
Scheduled
Jun 12
Form 4
—
0
$95.66
-$79,450.80
19.02K
Scheduled
Apr 28
Form 4
—
0
$102.53
-$2,945,996.32
19.02K
Scheduled
Apr 10
Form 4
—
0
—
—
0
Jan 17
Form 4
+41.27%
5.55K
—
—
19.02K
Jul 15
Form 4
+24.06%
2.61K
—
—
13.46K
Jan 7
Form 4
+38.61%
3.02K
—
—
10.85K
Jan 8
Form 4
∞
7.83K
—
—
7.83K
Oct 31
Form 3
—
0
—
—
0
No matching records found

COTHERIX INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Dec 28
Form 3
—
0
—
—
0
No matching records found

HYPERION THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 15
Form 3
—
0
—
—
0
No matching records found